Le Lézard
Classified in: Health, Business
Subjects: ACC, MAT

Global Consortium, Inc.'s Brand Indulge Oils Officially Begins Producing Crude Oil


COCONUT CREEK, Florida, March 23, 2020 /PRNewswire/ -- Global Consortium, Inc., (OTCPINK: GCGX) brand Indulge Oils is pleased to announce its Manufacturer has begun producing crude Oil which now activates its LOI for up to 25 liters of Oil per day at $7,000 per liter. Additionally, the Company is pleased to announce that the potency levels has exceeded expectations with potency tests showing mid to high 80s, which is considered "supreme" and will command greater than the estimated $7,000 per liter.

Our Manufacture is able to operate in CA since they hold a license for both Medical and Recreational.  With the lockdown in place for all of CA, Medical Cannabis has been deemed an essential business for the patients of CA who need their medicine. Therefore, our Manufacturer is deemed an essential business and able to fully operate during state wide lockdowns.

Indulge Oils will be listed as a financially interested party, under the Cannabis Manufacturing license and will receive 75% from all sales of liters of Oil under its brand name, furthermore Indulge will receive up 80% from the sale of all vape carts sold under its brand name.

CEO of Global Consortium (GCGX) had the following to say,

"When Indulge Oils was purchased two years ago, no one imagined it would take almost 2 years before production would begin. This finally puts the Company on track to begin booking revenue month over month. We had expected to book revenue for the first quarter, but the first sale is expected to take place in early April. The high grade crude produced from sourced crude should fetch a higher price due to its potency."

Any dispensaries or delivery businesses located in CA that are able to service the Medical Cannabis Market please visit www.IndulgeOils.com for more information. 

About Us:

Global Consortium, Inc., owns the brand Indulge Oils which will be manufactured and sold in California.

Global Consortium, Inc., in compliance with SEC regulations, may in the future use social media outlets like Facebook or Twitter and its own website to announce key information in compliance with Reg. FD.

Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, estimates of services and equipment markets, the release of corporate apps, growth of the platform, target markets, product releases, product demand and, business strategy. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also consider that any investment in securities is at risk.

Details of the Company's business, finances, appointments, and agreements can be found as part of the Company's continuous public disclosure on otcmarkets.com.

For additional information about this release please contact:

Global Consortium, Inc.
+1-954-906-0098
Investor Relations:
www.GCGX.ORG
[email protected]
Twitter: @Global_GCGXOTC

 


 

SOURCE Global Consortium, Inc.


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: